REVATIO Side Effects

7023610-4 | Foetal Growth Restriction, Premature Baby
on Sep 21, 2010 Female patient from GERMANY , weighting 3.70 lb, was diagnosed with pulmonary arterial hypertension, autoimmune thyroiditis, prophylaxis and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: foetal growth restriction, premature baby. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with EUTHYROX (100 Ug, 1x/day) (View Euthyrox Review and Euthyrox Label ), FOLIC ACID (1 Df, 1x/day) (View Folic Acid Review and Folic Acid Label ), FRAGMIN (Unk) (View Fragmin Review and Fragmin Label ), VITAMIN B 12 (1 Df, 1x/day) (View Vitamin B-12 Review and Vitamin B-12 Label ).

7022610-8 | Abasia, Paraesthesia
Patient was taking Revatio (View Usage). Patient had the following side effects: abasia, paraesthesia on Sep 22, 2010 from AUSTRALIA Additional patient health information: Female patient , 55 years of age, weighting 176.4 lb, was diagnosed with pulmonary arterial hypertension and. Revatio dosage: 20 Mg, 3x/day.

7022608-X | Pulmonary Hypertension
Adverse event was reported on Sep 23, 2010 by a Male patient taking Revatio (View Usage) (Dosage: 20 Mg, Unk) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: NETHERLANDS , 79 years of age, After Revatio was administered, patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?).

7022585-1 | Angina Pectoris, Oedema, Premature Labour
on Sep 21, 2010 Female patient from GERMANY , 29 years of age, weighting 121.3 lb, was diagnosed with pulmonary arterial hypertension, autoimmune thyroiditis, prophylaxis, vitamin supplementation and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, oedema, premature labour. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with EUTHYROX (100 Ug, 1x/day) (View Euthyrox Review and Euthyrox Label ), FOLIC ACID (1 Df, 1x/day) (View Folic Acid Review and Folic Acid Label ), FRAGMIN (Unk) (View Fragmin Review and Fragmin Label ), VITAMIN B 12 (Unk) (View Vitamin B-12 Review and Vitamin B-12 Label ).


7022538-3 | Hepatic Function Abnormal
on Sep 22, 2010 Male patient from JAPAN , 79 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient had the following side effects: hepatic function abnormal. Revatio dosage: Unk. During the same period patient was treated with TRACLEER (Unk) (View Tracleer Review and Tracleer Label ).

7022531-0 |
Patient was taking Revatio (View Usage). on Sep 24, 2010 from NETHERLANDS Additional patient health information: Female patient , 69 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: 20 Mg, Unk.

7019147-9 | Anaemia, Respiratory Distress, Tracheal Haemorrhage
Adverse event was reported on Sep 13, 2010 by a Male patient taking Revatio (View Usage) (Dosage: 1 Mg/kg Every 6 Hours) was diagnosed with pulmonary arterial hypertension, prophylaxis against gastrointestinal ulcer, endotracheal intubation, pain (What is pain?) and. Location: FRANCE , weighting 4.85 lb, Patient experienced the following unwanted or unexpected effects: anaemia, respiratory distress, tracheal haemorrhage. During the same period patient was treated with EUPANTOL (Unk) (View Eupantol Review and Eupantol Label ), FENTANYL (Unk) (View Fentanyl Review and Fentanyl Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ).

7018870-X | Abdominal Pain, Bladder Dilatation, Dyspnoea Exertional, Epistaxis, Faecaloma, Malaise, Pulmonary Embolism
on Sep 16, 2010 Male patient from GERMANY , 83 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), bladder dilatation, dyspnoea exertional, epistaxis, faecaloma, malaise, pulmonary embolism (What is pulmonary embolism?). Revatio dosage: Unk. During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ), ISOPTIN (Thrice Daily 1/2 Df (1 Df= 240)) (View Isoptin Review and Isoptin Label ), PREDNISOLON (10 Mg, 1x/day) (View Prednisolon Review and Prednisolon Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), XIPAMIDE (1/2 Df (1 Df = 10)/day) (View Xipamide Review and Xipamide Label ), SYMBICORT (1 Puff/day) (View Symbicort Review and Symbicort Label ), METFORMIN (View Metformin Review and Metformin Label ), TAMSULOSIN (0.4 Unk, 1x/day) (View Tamsulosin Review and Tamsulosin Label ). Patient was hospitalized.

7018826-7 | Abdominal Pain Upper, Convulsion, Cor Pulmonale, Decreased Appetite, Dizziness, Gastritis, Intestinal Infarction, Tachyarrhythmia, Vomiting
on Sep 16, 2010 Female patient from GERMANY , 79 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: abdominal pain upper, convulsion, cor pulmonale, decreased appetite, dizziness (What is dizziness?), gastritis, intestinal infarction, tachyarrhythmia, vomiting. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with AMLODIPINE/ HYDROCHLOROTHIAZIDE/ VALSARTAN (View Amlodipine/ Hydrochlorothiazide/ Valsartan Review and Amlodipine/ Hydrochlorothiazide/ Valsartan Label ), AMARYL (View Amaryl Review and Amaryl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ), NEXIUM (View Nexium Review and Nexium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ). Patient was hospitalized.

7018816-4 | Arrhythmia, Hypertension
Patient was taking Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), hypertension on Sep 16, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), renal transplant and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with PROGRAF (Unk) (View Prograf Review and Prograf Label ). Patient was hospitalized.

7016933-6 | Vision Blurred
Adverse event was reported on Sep 15, 2010 by a Female patient taking Revatio (View Usage) (Dosage: 20 Mg, 3x/day) was diagnosed with pulmonary arterial hypertension, hyperthyroidism and. Location: UNITED STATES , weighting 200.0 lb, Patient had the following side effects: vision blurred. During the same period patient was treated with VALSARTAN (320 Mg, Daily) (View Valsartan Review and Valsartan Label ), AMLODIPINE (5 Mg, Daily) (View Amlodipine Review and Amlodipine Label ), FUROSEMIDE (40 Mg, 2x/day) (View Furosemide Review and Furosemide Label ), LIPITOR (80 Mg, Daily) (View Lipitor Review and Lipitor Label ), ASPIRIN (81 Mg, Daily) (View Aspirin Review and Aspirin Label ), LEVOTHYROXINE (75 Mg, Daily) (View Levothyroxine Review and Levothyroxine Label ), PREDNISONE (10 Mg, Daily) (View Prednisone Review and Prednisone Label ), PRIMIDONE (50 Mg, Daily) (View Primidone Review and Primidone Label ).

7016352-2 |
on Sep 15, 2010 Female patient from CANADA , 73 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). . Revatio dosage: .

7013632-1 | Arthralgia, Ascites, Asthma, Catheterisation Cardiac, Cor Pulmonale, Echocardiogram Abnormal, Electrocardiogram Abnormal, Hepatic Congestion
on Sep 14, 2010 Male patient from UNITED STATES , weighting 221.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, ascites, asthma (What is asthma?), catheterisation cardiac, cor pulmonale, echocardiogram abnormal, electrocardiogram abnormal, hepatic congestion. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with TREPROSTINIL SODIUM (18 Ug, 4x/day) (View Treprostinil Sodium Review and Treprostinil Sodium Label ), WARFARIN (5 Mg, Alternate Days, On Tuesdays And Thursdays) (View Warfarin Review and Warfarin Label ), BUMETANIDE (4 Mg, 2x/day For 7 Days) (View Bumetanide Review and Bumetanide Label ), DIGOXIN (0.25 Mg, 1x/day) (View Digoxin Review and Digoxin Label ), POTASSIUM CHLORIDE (20 Meq, 2x/day) (View Potassium Chloride Review and Potassium Chloride Label ), OMEPRAZOLE (20 Mg, 1x/day, Every Morning) (View Omeprazole Review and Omeprazole Label ).

7010143-4 | Retinal Oedema, Visual Field Defect, Visual Impairment
Patient was taking Revatio (View Usage). Patient had the following side effects: retinal oedema, visual field defect, visual impairment on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 83.99 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ).

7007949-4 | Respiratory Failure
Adverse event was reported on Sep 15, 2010 by a Female patient taking Revatio (View Usage) (Dosage: Unk) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), persistent foetal circulation and. Location: JAPAN , weighting 1.34 lb, After Revatio was administered, patient had the following side effects: respiratory failure. During the same period patient was treated with NITRIC OXIDE (Unk) (View Nitric Oxide Review and Nitric Oxide Label ).

7007632-5 | Abdominal Pain, Bronchopneumonia, Cardiac Failure, Cardiopulmonary Failure, Cor Pulmonale, Electrolyte Imbalance, Embolism Arterial, Enterococcus Test Positive
on Sep 16, 2010 Female patient from GERMANY , 85 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), bronchopneumonia, cardiac failure, cardiopulmonary failure, cor pulmonale, electrolyte imbalance, embolism arterial, enterococcus test positive. Revatio dosage: 20 Mg, 3x/day.

7006095-3 | Respiratory Failure
on Sep 15, 2010 Male patient from AUSTRALIA , 64 years of age, was treated with Revatio (View Usage). Patient had the following side effects: respiratory failure. Revatio dosage: 20 Mg, 3x/day.

7003270-9 | Gastrointestinal Haemorrhage
Patient was taking Revatio (View Usage). After Revatio was administered, patient had the following side effects: gastrointestinal haemorrhage on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 217.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: 40 Mg, 3x/day. During the same period patient was treated with NAPROSYN (View Naprosyn Review and Naprosyn Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), OXYGEN (View Oxygen Review and Oxygen Label ), TYLENOL (View Tylenol Review and Tylenol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), TOPAMAX (View Topamax Review and Topamax Label ), THIAMINE (View Thiamine Review and Thiamine Label ). Patient was hospitalized.

7002181-2 | Anxiety, Ascites, Hypertension, Oedema, Right Ventricular Failure, Tachycardia
Adverse event was reported on Sep 08, 2010 by a Female patient taking Revatio (View Usage) (Dosage: 40 Mg, 3x/day) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 190.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), ascites, hypertension, oedema, right ventricular failure, tachycardia. During the same period patient was treated with REMODULIN (80 Ng/kg/min) (View Remodulin Review and Remodulin Label ), LASIX (60 Mg, 3x/day) (View Lasix Review and Lasix Label ), PREMARIN (Unk) (View Premarin Review and Premarin Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ).

7001682-0 | Deafness Bilateral, Fall, Hypotension, Pulmonary Hypertension
on Sep 13, 2010 Female patient from FRANCE , 77 years of age, weighting 116.8 lb, was diagnosed with pulmonary arterial hypertension, renal failure and was treated with Revatio (View Usage). Patient had the following side effects: deafness bilateral, fall (What is fall?), hypotension, pulmonary hypertension (What is pulmonary hypertension?). Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ), LASIX (80 Mg, 2x/day, Morning And Midday) (View Lasix Review and Lasix Label ), AMITRIPTYLINE HCL (5 Gouts On Evening) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), ALDACTONE (200 Once Daily) (View Aldactone Review and Aldactone Label ), CORTANCYL (7 Mg Daily) (View Cortancyl Review and Cortancyl Label ), NEXIUM (40 Mg Daily) (View Nexium Review and Nexium Label ), FERROUS SULFATE/FOLIC ACID (Unk) (View Ferrous Sulfate/folic Acid Review and Ferrous Sulfate/folic Acid Label ), CACIT D3 (Unk) (View Cacit D3 Review and Cacit D3 Label ). Patient was hospitalized.

6994349-6 | Abdominal Discomfort, Headache, Myalgia, Somnolence
on Aug 23, 2010 Female patient from UNITED STATES , 57 years of age, weighting 140.0 lb, was diagnosed with pulmonary arterial hypertension, type 2 diabetes mellitus and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: abdominal discomfort, headache (What is headache?), myalgia, somnolence. Revatio dosage: 20 Mg, Daily. During the same period patient was treated with LANTUS (Unk) (View Lantus Review and Lantus Label ).

6975900-9 | Right Ventricular Failure
Patient was taking Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: right ventricular failure on Sep 01, 2010 from NETHERLANDS Additional patient health information: Female patient , 57 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: 20 Mg, Unk.

6975893-4 |
Adverse event was reported on Sep 01, 2010 by a Male patient taking Revatio (View Usage) (Dosage: 40 Mg, 3x/day) was diagnosed with pulmonary arterial hypertension and. Location: AUSTRALIA , 44 years of age, .

6971901-5 | Distal Ileal Obstruction Syndrome
on Sep 08, 2010 Female patient from UNITED STATES , weighting 107.1 lb, was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: distal ileal obstruction syndrome. Revatio dosage: 20 Mg P.o. T.i.d.. During the same period patient was treated with LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), NASACORT (View Nasacort Review and Nasacort Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), HUMALOG (View Humalog Review and Humalog Label ). Patient was hospitalized.

6967759-0 | Flushing, Hot Flush, Hypersensitivity, Local Swelling, Swelling Face
on Aug 26, 2010 Female patient from GERMANY , 53 years of age, was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: flushing, hot flush, hypersensitivity, local swelling, swelling face. Revatio dosage: Unk.

6967671-7 | Hypoacusis, Intervertebral Disc Compression, Vision Blurred
Patient was taking Revatio (View Usage). Patient had the following side effects: hypoacusis, intervertebral disc compression, vision blurred on Aug 26, 2010 from FRANCE Additional patient health information: Female patient , 81 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), pulmonary arterial hypertension, chronic obstructive pulmonary disease and. Revatio dosage: Unk. During the same period patient was treated with AMBRISENTAN (Unk) (View Ambrisentan Review and Ambrisentan Label ), FLIXOTIDE DISKUS (Unk) (View Flixotide Diskus Review and Flixotide Diskus Label ), VENTOLIN (Unk) (View Ventolin Review and Ventolin Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), PREVISCAN (Unk) (View Previscan Review and Previscan Label ), ACETAMINOPHEN (Unk) (View Acetaminophen Review and Acetaminophen Label ), INIPOMP (Unk) (View Inipomp Review and Inipomp Label ).

6965352-7 | Diabetes Mellitus, Disease Progression, Hypertension, Pulmonary Hypertension
Adverse event was reported on Aug 26, 2010 by a Female patient taking Revatio (View Usage) (Dosage: 20 Mg, Unk) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 187.0 lb, After Revatio was administered, patient had the following side effects: diabetes mellitus, disease progression, hypertension, pulmonary hypertension (What is pulmonary hypertension?).

6964499-9 | Interstitial Lung Disease, Pyrexia, Urticaria
on Aug 23, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pyrexia, urticaria. Revatio dosage: 60 Mg, 1x/day. During the same period patient was treated with BOSENTAN (Unk) (View Bosentan Review and Bosentan Label ), PROCYLIN (Unk) (View Procylin Review and Procylin Label ). Patient was hospitalized.

6963751-0 | Pulmonary Oedema
on Aug 25, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), cardiac disorder and was treated with Revatio (View Usage). Patient had the following side effects: pulmonary oedema. Revatio dosage: Unk Mg, 2x/day. During the same period patient was treated with FEXOFENADINE (Unk) (View Fexofenadine Review and Fexofenadine Label ), HYDRALAZINE (Unk) (View Hydralazine Review and Hydralazine Label ), ACETYLSALICYLIC ACID (81 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), WARFARIN SODIUM (Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ), VITAMINS (Unk) (View Vitamins Review and Vitamins Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ). Patient was hospitalized.

6963532-8 | Abasia, Dyspnoea, Fatigue
Patient was taking Revatio (View Usage). After Revatio was administered, patient had the following side effects: abasia, dyspnoea, fatigue on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 234.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), angina pectoris, cardiac failure congestive, hypothyroidism, dyspnoea, blood potassium decreased and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with ACETYLSALICYLIC ACID (81 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), DIAMOX SRC (2 Mg, 2x/day) (View Diamox Src Review and Diamox Src Label ), SYNTHROID (112 Ug, 1x/day) (View Synthroid Review and Synthroid Label ), COMBIVENT (Unk) (View Combivent Review and Combivent Label ), GABAPENTIN (300 Mg, 1x/day) (View Gabapentin Review and Gabapentin Label ), COZAAR (100 Mg, 1x/day) (View Cozaar Review and Cozaar Label ), POTASSIUM CHLORIDE (20 Meq, As Needed) (View Potassium Chloride Review and Potassium Chloride Label ), HYDROCORTISONE (40 Mg, 2x/day) (View Hydrocortisone Review and Hydrocortisone Label ).

6961445-9 | Erectile Dysfunction
Adverse event was reported on Aug 24, 2010 by a Male patient taking Revatio (View Usage) (Dosage: 20 Mg, 3x/day) was diagnosed with pulmonary arterial hypertension, tachycardia and. Location: GERMANY , 65 years of age, Patient experienced the following unwanted or unexpected effects: erectile dysfunction (What is erectile dysfunction?). During the same period patient was treated with CARVEDILOL (12.5 Mg, Unk) (View Carvedilol Review and Carvedilol Label ), CLEXANE (0.9 Ml, 2x/day) (View Clexane Review and Clexane Label ), XIPAMIDE (10 Mg, Unk) (View Xipamide Review and Xipamide Label ), TORASEMIDE (20 Mg, 2x/day) (View Torasemide Review and Torasemide Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ).

6961197-2 | Arrhythmia, Hypertension
on Aug 20, 2010 Female patient from UNITED STATES , weighting 125.7 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), renal transplant and was treated with Revatio (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), hypertension. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with PROGRAF (Unk) (View Prograf Review and Prograf Label ). Patient was hospitalized.

6955471-3 | Colon Cancer, Pneumonia Bacterial, Renal Failure, Sepsis, Shock, Superinfection
on Aug 18, 2010 Male patient from FRANCE , 64 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: colon cancer, pneumonia bacterial, renal failure, sepsis (What is sepsis?), shock, superinfection. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with TRACLEER (Unk) (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

6939976-7 | Abdominal Pain Upper, Convulsion, Cor Pulmonale, Decreased Appetite, Dizziness, Gastritis, Intestinal Infarction, Tachyarrhythmia, Vomiting
Patient was taking Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, convulsion, cor pulmonale, decreased appetite, dizziness (What is dizziness?), gastritis, intestinal infarction, tachyarrhythmia, vomiting on Aug 12, 2010 from GERMANY Additional patient health information: Female patient , 79 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with AMLODIPINE/ HYDROCHLOROTHIAZIDE/ VALSARTAN (View Amlodipine/ Hydrochlorothiazide/ Valsartan Review and Amlodipine/ Hydrochlorothiazide/ Valsartan Label ), AMARYL (View Amaryl Review and Amaryl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ), NEXIUM (View Nexium Review and Nexium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ). Patient was hospitalized.

6939943-3 | Abdominal Pain, Bladder Dilatation, Dyspnoea Exertional, Epistaxis, Faecaloma, Malaise, Pulmonary Embolism
Adverse event was reported on Aug 12, 2010 by a Male patient taking Revatio (View Usage) (Dosage: Unk) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: GERMANY , 83 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), bladder dilatation, dyspnoea exertional, epistaxis, faecaloma, malaise, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ), ISOPTIN (Thrice Daily 1/2 Df (1 Df= 240)) (View Isoptin Review and Isoptin Label ), PREDNISOLON (10 Mg, 1x/day) (View Prednisolon Review and Prednisolon Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), XIPAMIDE (1/2 Df (1 Df = 10)/day) (View Xipamide Review and Xipamide Label ), SYMBICORT (1 Puff/day) (View Symbicort Review and Symbicort Label ), METFORMIN (View Metformin Review and Metformin Label ), TAMSULOSIN (0.4 Unk, 1x/day) (View Tamsulosin Review and Tamsulosin Label ). Patient was hospitalized.

6939175-9 | Abdominal Pain, Bronchopneumonia, Cardiac Failure, Cardiopulmonary Failure, Cor Pulmonale, Electrolyte Imbalance, Embolism Arterial, Enterococcus Test Positive
on Aug 12, 2010 Female patient from GERMANY , 85 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), bronchopneumonia, cardiac failure, cardiopulmonary failure, cor pulmonale, electrolyte imbalance, embolism arterial, enterococcus test positive. Revatio dosage: 20 Mg, 3x/day.

6936525-4 | Dyspnoea, Fear Of Falling, Gait Disturbance, Musculoskeletal Pain, Nasopharyngitis, Pain In Extremity, Visual Impairment, Weight Decreased
on Aug 11, 2010 Male patient from UNITED STATES , weighting 160.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), hypoventilation, arthritis (What is arthritis?), cardiac disorder, fluid retention and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, fear of falling, gait disturbance, musculoskeletal pain, nasopharyngitis, pain in extremity, visual impairment, weight decreased. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with DICLOFENAC (75 Mg, Unk) (View Diclofenac Review and Diclofenac Label ), DIGOXIN (0.125 Mg, Unk) (View Digoxin Review and Digoxin Label ), FUROSEMIDE (20 Mg, Unk) (View Furosemide Review and Furosemide Label ), ACEBUTOLOL (200 Mg, 2x/day) (View Acebutolol Review and Acebutolol Label ), KLOR CON (20 Mg, 1x/day) (View Klor-con Review and Klor-con Label ), LISINOPRIL (2.5 Mg, 1x/day) (View Lisinopril Review and Lisinopril Label ), AMLODIPINE (2.5 Mg, Unk) (View Amlodipine Review and Amlodipine Label ).

6936260-2 | Pulmonary Hypertension
Patient was taking Revatio (View Usage). Patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?) on Aug 11, 2010 from NETHERLANDS Additional patient health information: Male patient , 60 years of age, . Revatio dosage: 20 Mg, Unk.

6928949-6 | Cardiac Arrest
Adverse event was reported on Aug 05, 2010 by a Male patient taking Revatio (View Usage) (Dosage: 20 Mg, 3x/day) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , weighting 178.0 lb, After Revatio was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with DIGOXIN (Unk) (View Digoxin Review and Digoxin Label ), SPIRONOLACTONE (Unk) (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), SPIRIVA (Unk (inhaler)) (View Spiriva Review and Spiriva Label ), WARFARIN (Unk) (View Warfarin Review and Warfarin Label ), PROAIR HFA (Unk, (inhaler) As Needed) (View Proair Hfa Review and Proair Hfa Label ), ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6928490-0 | Gastrointestinal Disorder
on Aug 05, 2010 Male patient from UNITED STATES , weighting 198.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal disorder. Revatio dosage: 10 Mg, 2x/day. During the same period patient was treated with XOPENEX (45 Ug, As Needed) (View Xopenex Review and Xopenex Label ), SPIRIVA (18 Ug, Unk) (View Spiriva Review and Spiriva Label ), KEPPRA (750 Mg, Daily) (View Keppra Review and Keppra Label ), ZITHROMAX (215 Mg, Daily) (View Zithromax Review and Zithromax Label ), BACTRIM DS (Unk, 2x/week) (View Bactrim Ds Review and Bactrim Ds Label ), VITAMIN D (400 Iu, Daily) (View Vitamin D Review and Vitamin D Label ), OS CAL (600 Mg, 3x/day) (View Os-cal Review and Os-cal Label ).

6923026-2 |
on Aug 04, 2010 Male patient from NETHERLANDS , 65 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). . Revatio dosage: 20 Mg, Unk.

6919861-7 | Dysgeusia, Rhinorrhoea, Sputum Increased, Tremor
Patient was taking Revatio (View Usage). After Revatio was administered, patient had the following side effects: dysgeusia, rhinorrhoea, sputum increased, tremor on Jul 28, 2010 from CANADA Additional patient health information: Male patient , 88 years of age, . Revatio dosage: 20 Mg, Unk. During the same period patient was treated with FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), AMIODARONE (Unk) (View Amiodarone Review and Amiodarone Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), WARFARIN SODIUM (Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ).

6919195-0 | Cardiac Failure Congestive
Adverse event was reported on Jul 30, 2010 by a Male patient taking Revatio (View Usage) (Dosage: 40 Mg, 1x/day) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , weighting 270.0 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive.

6918637-4 | Aplastic Anaemia, Platelet Count Decreased
on Jul 30, 2010 Female patient from JAPAN , 38 years of age, weighting 112.4 lb, was diagnosed with pulmonary arterial hypertension, anaemia, prophylaxis against gastrointestinal ulcer and was treated with Revatio (View Usage). Patient had the following side effects: aplastic anaemia, platelet count decreased. Revatio dosage: 20 Mg, 2x/day. During the same period patient was treated with BERAPROST SODIUM (60 Ug, 2x/day) (View Beraprost Sodium Review and Beraprost Sodium Label ), MUCOSTA (100 Mg, 2x/day) (View Mucosta Review and Mucosta Label ), FERROMIA (50 Mg, 2x/day) (View Ferromia Review and Ferromia Label ), TAKEPRON (15 Mg, 1x/day) (View Takepron Review and Takepron Label ).

6914445-9 | Foetal Growth Restriction, Premature Baby
on Jul 28, 2010 Female patient from GERMANY , weighting 3.70 lb, was diagnosed with pulmonary arterial hypertension, autoimmune thyroiditis, prophylaxis and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: foetal growth restriction, premature baby. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FOLIC ACID (1 Df, 1x/day) (View Folic Acid Review and Folic Acid Label ), FRAGMIN (Unk) (View Fragmin Review and Fragmin Label ), VITAMIN B 12 (1 Df, 1x/day) (View Vitamin B-12 Review and Vitamin B-12 Label ).

6914131-5 | Angina Pectoris, Oedema, Premature Labour
Patient was taking Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, oedema, premature labour on Jul 28, 2010 from GERMANY Additional patient health information: Female patient , 29 years of age, weighting 121.3 lb, was diagnosed with pulmonary arterial hypertension, autoimmune thyroiditis, prophylaxis, vitamin supplementation and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FOLIC ACID (1 Df, 1x/day) (View Folic Acid Review and Folic Acid Label ), FRAGMIN (Unk) (View Fragmin Review and Fragmin Label ), VITAMIN B 12 (Unk) (View Vitamin B-12 Review and Vitamin B-12 Label ).

6910890-6 | Abdominal Pain, Constipation, Dyspnoea Exertional, Epistaxis, Malaise
Adverse event was reported on Jul 26, 2010 by a Male patient taking Revatio (View Usage) (Dosage: Unk) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: GERMANY , 83 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), dyspnoea exertional, epistaxis, malaise. During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

6910757-3 | Abdominal Pain Upper, Convulsion, Decreased Appetite, Gastritis, Intestinal Infarction, Tachyarrhythmia, Vomiting, Weight Decreased
on Jul 26, 2010 Female patient from GERMANY , 79 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: abdominal pain upper, convulsion, decreased appetite, gastritis, intestinal infarction, tachyarrhythmia, vomiting, weight decreased. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with AMLODIPINE/ HYDROCHLOROTHIAZIDE/ VALSARTAN (View Amlodipine/ Hydrochlorothiazide/ Valsartan Review and Amlodipine/ Hydrochlorothiazide/ Valsartan Label ), AMARYL (View Amaryl Review and Amaryl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ), NEXIUM (View Nexium Review and Nexium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ). Patient was hospitalized.

6910416-7 |
on Jul 26, 2010 Male patient from NETHERLANDS , 65 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). . Revatio dosage: 20 Mg, Unk.

6910404-0 | Activities Of Daily Living Impaired, Condition Aggravated, Diastolic Dysfunction, Feeling Abnormal, Vitamin D Deficiency
Patient was taking Revatio (View Usage). Patient had the following side effects: activities of daily living impaired, condition aggravated, diastolic dysfunction, feeling abnormal, vitamin d deficiency on Jul 26, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 160.0 lb, was diagnosed with pulmonary arterial hypertension, diabetes mellitus and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with METOPROLOL (Unk) (View Metoprolol Review and Metoprolol Label ), METFORMIN (Unk) (View Metformin Review and Metformin Label ).